‹³ˆõî•ñ
Ž–¼ A“c@Œ\—S
ƒtƒŠƒKƒi ƒEƒGƒ_@ƒPƒCƒXƒP
E–¼ •‹³
ŠwˆÊ ”ŽŽmi–ò‰ÈŠwj
Œ¤‹†Žº »ÜHŠw
“d˜b”ԍ† 043-226-2866
ƒ[ƒ‹ƒAƒhƒŒƒX keisuke—faculty.chiba-u.jp@i—‚Í‘SŠp•\‹Lj
’S“–u‹` •¨—ŠwŠî‘bŽÀŒ±I
–òÜŠwII
•¨—‰»ŠwIV
–òÜŠwIII
»ÜHŠw
ê–啪–ì »ÜŠw
•¨—–òŠw
Œ¤‹†ƒe[ƒ} “—n«–ò•¨‚Ì—n‰ð«‰ü‘P‹Zp‚ÌŠJ”­‚Æ‹@\‰ð–¾
Žå‚ÈŒ¤‹†‹ÆÑ Ueda, K., Higashi, K., Yamamoto, K., Moribe, K.: Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using 1H NMR technique. Mol. Pharm. 12(4)A1096-1104(in press)

Ueda, K., Higashi, K., Kataoka, M., Yamashita, S., Yamamoto, K., Moribe, K.: Inhibition mechanism of hydroxypropyl methylcellulose acetate succinate on drug crystallization in gastrointestinal fluid and drug permeability from a supersaturated solution. Eur. J. Pharm. Sci. 62, 293-300 (2014)

Ueda, K., Higashi, K., Yamamoto, K., Moribe, K.: The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement. Int. J. Pharm. 464 (1?2), 205-213 (2014)

Ueda, K., Higashi, K., Yamamoto, K., Moribe, K.: Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurements. Mol. Pharm. 10 (10), 3801-3811 (2013)

Ueda, K., Higashi, K., Limwikrant, W., Sekine, S., Horie, T., Yamamoto, K., Moribe, K.: Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements. Mol. Pharm. 9 (11), 3023-3033 (2012)
Š‘®Šw‰ï “ú–{–òŠw‰ï
“ú–{–òÜŠw‰ï
ƒAƒƒŠƒJ–òÜŠw‰ï
»Ü‹@ŠB‹ZpŒ¤‹†‰ï
ŠwŠO‚Å‚Ì‹³ˆçEŒ¤‹†Šˆ“® @